Peter Oturai

3.3k total citations
109 papers, 2.4k citations indexed

About

Peter Oturai is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Peter Oturai has authored 109 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 25 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Peter Oturai's work include Neuroendocrine Tumor Research Advances (24 papers), Neuroblastoma Research and Treatments (19 papers) and Lung Cancer Research Studies (15 papers). Peter Oturai is often cited by papers focused on Neuroendocrine Tumor Research Advances (24 papers), Neuroblastoma Research and Treatments (19 papers) and Lung Cancer Research Studies (15 papers). Peter Oturai collaborates with scholars based in Denmark, Australia and United Kingdom. Peter Oturai's co-authors include Andreas Kjær, Ulrich Knigge, Jann Mortensen, Annika Loft, Seppo W. Langer, Anne Kiil Berthelsen, Jes Olesen, Camilla Bardram Johnbeck, Dennis Ringkjøbing Elema and Messoud Ashina and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Peter Oturai

103 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Oturai Denmark 27 854 659 479 425 297 109 2.4k
Leszek Królicki Poland 30 573 0.7× 671 1.0× 1.1k 2.3× 731 1.7× 203 0.7× 186 3.0k
Roy Moncayo Austria 28 582 0.7× 712 1.1× 637 1.3× 560 1.3× 112 0.4× 109 2.7k
Iryna Lobach United States 26 444 0.5× 369 0.6× 595 1.2× 284 0.7× 203 0.7× 67 3.4k
Yodphat Krausz Israel 25 420 0.5× 487 0.7× 549 1.1× 408 1.0× 133 0.4× 76 2.1k
Kiyoshi Koizumi Japan 28 420 0.5× 283 0.4× 496 1.0× 289 0.7× 374 1.3× 244 2.8k
Marie‐Laure Tanguy France 30 296 0.3× 351 0.5× 300 0.6× 382 0.9× 301 1.0× 65 3.1k
D. Huglo France 29 561 0.7× 476 0.7× 868 1.8× 435 1.0× 840 2.8× 120 3.6k
Diego Cecchin Italy 23 303 0.4× 230 0.3× 544 1.1× 309 0.7× 145 0.5× 156 1.8k
Duccio Volterrani Italy 29 285 0.3× 205 0.3× 651 1.4× 816 1.9× 345 1.2× 154 3.1k
Ernst Moser Germany 20 394 0.5× 405 0.6× 808 1.7× 399 0.9× 145 0.5× 57 2.3k

Countries citing papers authored by Peter Oturai

Since Specialization
Citations

This map shows the geographic impact of Peter Oturai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Oturai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Oturai more than expected).

Fields of papers citing papers by Peter Oturai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Oturai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Oturai. The network helps show where Peter Oturai may publish in the future.

Co-authorship network of co-authors of Peter Oturai

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Oturai. A scholar is included among the top collaborators of Peter Oturai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Oturai. Peter Oturai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borgwardt, Lise, Jesper Brok, Kim Francis Andersen, et al.. (2024). Performing [18F]MFBG Long–Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma. Journal of Nuclear Medicine. 65(8). 1286–1292. 9 indexed citations
2.
Carlsen, Esben Andreas, Camilla Bardram Johnbeck, Ulrich Knigge, et al.. (2024). Routine Use of [64Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans. Journal of Nuclear Medicine. 65(11). 1754–1761. 1 indexed citations
3.
Oturai, Peter, et al.. (2024). Acute response to resistance exercise and later development of arm lymphedema in breast cancer survivors: An exploratory follow-up of a randomized cross-over trial. SHILAP Revista de lepidopterología. 3. 100057–100057. 1 indexed citations
4.
Sjöstedt, Sannia, Christoffer Holst Hahn, Åse Krogh Rasmussen, Peter Oturai, & Per Karkov Cramon. (2024). Abnormal uptake related to the thyroid gland on somatostatin receptor-targeted PET imaging: reported prevalence and rate of thyroid malignancy and parathyroid adenomas. Endocrine Connections. 13(12). 1 indexed citations
5.
Lundby, Carsten, et al.. (2023). Intravascular volumes and the influence on anemia assessed by a carbon monoxide rebreathing method in patients undergoing maintenance hemodialysis. Hemodialysis International. 28(1). 40–50. 1 indexed citations
6.
Krogh, Jesper, Ulla Feldt‐Rasmussen, Åse Krogh Rasmussen, et al.. (2023). Imaging surveillance in multiple endocrine neoplasia type 1: Ten years of experience with somatostatin receptor positron emission tomography. Journal of Neuroendocrinology. 35(8). e13322–e13322.
7.
Jørgensen, Poul, Michael Kreiberg, Niels Jørgensen, et al.. (2023). Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors – results from a randomized double-blind trial. Acta Oncologica. 62(7). 689–695. 2 indexed citations
8.
Winsløw, Ulrik, Ketil Haugan, Niels Eske Bruun, et al.. (2023). Treatment-induced increase in total body potassium in patients at high risk of ventricular arrhythmias; a randomized POTCAST substudy. PLoS ONE. 18(7). e0288756–e0288756. 2 indexed citations
9.
Kreiberg, Michael, Niels Jørgensen, Anders Juul, et al.. (2022). A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention). Clinical Genitourinary Cancer. 20(5). 404–414. 4 indexed citations
10.
Møller, Tom, Christina Andersen, Christian Lillelund, et al.. (2020). Physical deterioration and adaptive recovery in physically inactive breast cancer patients during adjuvant chemotherapy: a randomised controlled trial. Scientific Reports. 10(1). 9710–9710. 33 indexed citations
11.
Jensen, Rikke Beck, Sine Knorr, Morten Frost Nielsen, et al.. (2020). Impact of Lean Body Mass and Insulin Sensitivity on the IGF-1–Bone Mass Axis in Adolescence: the EPICOM Study. The Journal of Clinical Endocrinology & Metabolism. 106(2). e772–e781. 5 indexed citations
12.
Petersen, Jørgen Holm, Åse Krogh Rasmussen, Allan M. Lund, et al.. (2018). Age-related renal function decline in Fabry disease patients on enzyme replacement therapy: a longitudinal cohort study. Nephrology Dialysis Transplantation. 34(9). 1525–1533. 26 indexed citations
13.
Bandak, Mikkel, Niels Jørgensen, Anders Juul, et al.. (2017). A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention). BMC Cancer. 17(1). 461–461. 10 indexed citations
14.
Johnbeck, Camilla Bardram, Ulrich Knigge, Annika Loft, et al.. (2016). Head-to-Head Comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors. Journal of Nuclear Medicine. 58(3). 451–457. 162 indexed citations
15.
Oturai, Peter, et al.. (2016). Forty-five-year follow-up on the renal function after spinal cord injury. Spinal Cord. 54(6). 445–451. 17 indexed citations
16.
Lauritsen, Jakob, Maria Gry Gundgaard, Mette Saksø Mortensen, et al.. (2014). Reliability of estimated glomerular filtration rate in patients treated with platinum containing therapy. International Journal of Cancer. 135(7). 1733–1739. 15 indexed citations
17.
Larsen, Julie Rask, Louise Vedtofte, Jens J. Holst, et al.. (2014). Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial. BMJ Open. 4(3). e004227–e004227. 18 indexed citations
18.
Pfeifer, Andreas, Camilla Bardram Johnbeck, Ulrich Knigge, et al.. (2013). Clinical PET imaging of neuroendocrine tumors using 64Cu-DOTA-Tyr3-octreotate. 54(6). 1854–1854. 5 indexed citations
19.
Oturai, Peter. (1999). EFFECTS OF HEPARIN ON VASCULAR DYSFUNCTION IN DIABETIC RATS. Clinical and Experimental Pharmacology and Physiology. 26(5-6). 411–414. 6 indexed citations
20.
Oturai, Peter, Niels Henrik Holländer, Ole Hansen, et al.. (1993). Ceftriaxone versus latamoxef in febrile neutropenic patients: Empirical monotherapy in patients with solid tumours. European Journal of Cancer. 29(9). 1274–1279. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026